NRTI drugs are pharmacologic agents that share a common mechanism (typically targeting Reverse transcriptase). 0 are currently marketed, with 2 more in clinical development.

NRTI

0 marketed 2 in Phase 3

This page covers all NRTI drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Reverse transcriptase.

Targets

Reverse transcriptase

Phase 3 pipeline (2)

Switch from tenofovir to abacavir · Germans Trias i Pujol Hospital · Infectious Diseases
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) that works by inhibiting the replication of HIV.
TRUVADA™ or EPZICOM™/KIVEXA™ · Merck Sharp & Dohme LLC · Infectious Disease
TRUVADA and EPZICOM/KIVEXA are antiretroviral medications used to treat HIV-1 infection by inhibiting viral replication.